20 October 2025 • 8 minute read
Biotech and Medtech Bootcamp
For Pre‑IPO and Growth‑Stage CompaniesOn Monday, October 20, 2025, DLA Piper and leading industry advisors conducted a bootcamp built for the C-suite of pre‑IPO and growth‑stage biotech and medtech companies at DLA Piper's New York office. They covered:
- Late-stage financing
- Standard and alternative capital markets pathways to going public
- Financial preparedness
- Regulatory considerations
- Compliance essentials
- IP strategy
- Licensing & partnering agreements
For more information on this event, reach out to Brandon McAfee.
Market Edge
Timely insights, market trends
Market Edge readies issuers and underwriters, public company boards and other market players with the tools necessary to keep up with the latest trends and best practices, optimizing business strategies and catalyzing growth.
Market Edge BlogAgenda and recordings
Speakers:
- Moderator: Josh Kaufman, Partner, Co-Chair, Capital Markets and Public Company Advisory Practice, DLA Piper
- Brian Gleason, Raymond James
- Susanne S. Mulligan, Cantor Fitzgerald
- David Kellman, Citizens Capital Markets & Advisory
Speakers:
- Steve Alicanti, Partner, DLA Piper
- Andrew Ledbetter, Partner, DLA Piper
Speakers:
- Dan Berenson, Citizens Capital Markets & Advisory
- Michael Friedman, Emerald Bioventures
Speakers:
- Moderator: Scott Cowan, Partner, DLA Piper
- George Santo, J.P. Morgan
- Artavazd Arumov, Qiming Venture Partners USA
- Kerra Melvin, Partner, DLA Piper
Speakers:
- Bennett Blau, Evercore
- Sachin Aggarwal, Evercore
Speaker:
- Gaeton Biscardi, Stout
- Kelly Provost, Stout
Speaker:
- Jeff Scott, Of Counsel, DLA Piper
Speakers:
- Chris Mikson, Partner, DLA Piper
- Preeya Pinto, Partner, DLA Piper
- Marco de Morpurgo, Partner, Global Co-Chair, Life Sciences Sector, DLA Piper
Speakers:
- Lisa Haile, Partner, DLA Piper
- Pierre De Oliveira, Partner, DLA Piper
- Ray Miller, Partner, US Chair, Life Sciences Patent Development & Strategy, DLA Piper
Speakers:
- Lauren Murdza, Partner, Co-Chair, Technology and Life Sciences Licensing and Commercial Transactions, DLA Piper
- James McGraw, Associate, DLA Piper
Speakers
| Sarchin Aggarwal Evercore |
Michael Friedman Emerald Bioventures |
| Bryan Gleason Raymond James |
David Kellman Citizens Capital Markets & Advisory |
| Susanne S. Mulligan Cantor Fitzgerald |
Dan Berenson Citizens Capital Markets & Advisory |
| Gaeton Biscardi Stout |
|
| Josh Kaufman Partner, Co-Chair, Capital Markets and Public Company Advisory Practice, US-LatAm Practice Group Regional Co-Leader, Capital Markets DLA Piper |
Larry W. Nishnick Partner, Chair, Southern California Corporate and Securities DLA Piper |
| Emilio Ragosa Partner DLA Piper |
Jeffrey Scott Of Counsel DLA Piper |
| Stephen P. Alicanti Partner, Member, Policy Committee Chair, New York Corporate Practice DLA Piper |
Scott Cowan Partner, Chair, New Jersey Corporate Group DLA Piper |
| Pierre De Oliveira, Ph.D. Partner DLA Piper |
Andrew D. Ledbetter Partner DLA Piper |
| Lauren Murdza Partner, Co-Chair, Technology and Life Sciences Licensing and Commercial Transactions DLA Piper |
James Patrick McGraw Associate DLA Piper |
| Christopher M. Mikson M.D., J.D. Partner DLA Piper |
Raymond Miller Partner, US Chair, Life Sciences Patent Development & Strategy DLA Piper |
| Lisa A. Haile, Ph.D. Partner DLA Piper |
Preeya Pinto Partner DLA Piper |